Webinar: China Cosmetic Regulation ImplementationApr 08, 2021 11:00am
China recently published three final versions of the implementing regulations that go into effect on May 1, 2021. The Administrative Measures for Cosmetic Registration provides the basic outline of registration requirements and filing management of cosmetics and new cosmetic ingredients. Detailed cosmetic product registration requirements and new ingredient registration steps are in the New Cosmetic Ingredient Registration and Cosmetic Product Registration and Notification Regulations. Critical elements of these measures include new data requirements for filing and registering products and ingredients, conditions for exemption from animal testing, and roles and responsibilities of responsible persons.
On Thursday, April 8, 11 a.m. – 12:30 p.m. EST, join PCPC and John Balzano, partner in Covington & Burling’s China practice, to learn more about the progress on Cosmetic Supervision and Administration Regulation implementation regulations, focusing on the recently finalized rules and standards on product and ingredient registration and notification. The presentation will cover how the latest rules will change the approval process for products and ingredients, including key issues such as animal testing, product standards, responsible persons and quality systems, as well as license amendment, renewal and transfer.
Balzano has more than 15 years of experience with legal and regulatory issues related to China, particularly with regard to products regulated by the State Administration for Market Regulation, the National Medical Products Administration (NMPA) and other agencies in China, including drugs, devices and cosmetics, as well as food products and other agriculture, animal and healthcare products and services. He assists clients with developing strategies to obtain pre-market approvals for these products, including clinical development, understanding relevant pricing and reimbursement policies, and reviewing distribution and promotional plans. He advises on regulatory compliance, due diligence and enforcement matters for China operations, and he assists companies and industry associations with their advocacy strategies, including the notice and comment process before NMPA and other regulatory agencies.